Bristol-Myers Squibb sell Barclays PLC
Start price
07.10.24
/
50%
€48.85
Target price
07.10.25
€39.19
Performance (%)
-20.99%
End price
08.10.25
€38.60
Summary
This prediction ended on 08.10.25 with a price of €38.60. The price of Bristol-Myers Squibb decreased from the start of the prediction. Compared to the start price this resulted in a performance of -20.99%. Barclays_PLC has a follow-up prediction for Bristol-Myers Squibb, but this time predicts that Bristol-Myers Squibb is a Buy. A total of €0.60 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -1.218% | -1.218% | 43.789% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by Barclays_PLC for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target raised by analysts at Barclays PLC from $42.00 to $43.00. They now have an "underweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€50.83
21.02.26
21.02.26
€63.65
21.02.27
21.02.27
8.36%
07.08.26
07.08.26
Stopped prediction by Barclays_PLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€42.92
22.08.24
22.08.24
€37.80
22.08.25
22.08.25
-4.19%
23.08.25
23.08.25